Drawing for ABC-19

USPTO serial 88875441

ABC-19

Reviewed by CopyMark Law Group

Reg. 6631129Status 700Renewal
Filing date
Status date
Registration date
Feb 1, 2022
Examiner
SCHIMPF, TIMOTHY O
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ABC-19?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,144*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Louise Arnott

Louise Arnott MICHAEL BEST & FRIEDRICH LLP444 W. LAKE STREET, SUITE 3200CHICAGO, IL 60606UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medical diagnostic reagents; diagnostic preparations for medical purposes; kits comprised of diagnostic reagents for medical use; medical diagnostic test strips for use in detecting viruses and antibodies to viruses; immunoassay diagnostic reagents for medical use; lateral flow diagnostic assay test strips for use in detecting viruses and antibodies to viruses; diagnostic preparations for medical and veterinary purposes; reagents and test strips for medical diagnostic use in detecting the presence of nucleic acid targets, and indicators of diseases, such indicators including enzymes, antigens, antibodies and nucleic acids; immunoassay reagents for medical use; all of the above for use in detecting viruses including coronaviruses and antibodies to viruses including coronavirusesACTIVE—
009Scientific, research, optical, weighing, measuring, detecting and testing apparatus and instruments, namely, research laboratory analysers for measuring, testing and analysing blood and other bodily fluids; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; downloadable mobile applications for reading, analysing, sending, receiving, and displaying medical and veterinary diagnostic testing data; downloadable computer software for reading, analysing, sending, receiving, and displaying medical and veterinary diagnostic testing data; downloadable computer software for reading, analysing, sending, receiving, and displaying medical and veterinary diagnostic testing data from lateral flow readers, and other diagnostic apparatus and instruments; computer hardware for storing, processing, and transmitting data; research laboratory analysers for measuring, testing and analysing blood and other bodily fluids, namely, lateral flow readers, not for medical purposes; all of the above for use in detecting viruses including coronavirusesACTIVE—
010Medical apparatus and instruments, namely, blood testing apparatus; tools for medical diagnostics, namely, medical diagnostic apparatus for testing for viruses and antibodies to viruses, lancets, dropping pipettes for medical purposes, bags for medical waste; tools for veterinary diagnostics, namely, lancets, dropping pipettes for veterinary purposes, bags for veterinary waste; medical diagnostic apparatus for testing for viruses and antibodies to viruses; medical testing equipment and apparatus, namely, medical diagnostic apparatus for testing for viruses and antibodies to viruses; apparatus for use in medical analysis, namely, medical diagnostic apparatus for testing for viruses and antibodies to viruses; kits for testing for the presence of analytes in biological fluids, other fluids and other matrices, all for medical purposes; medical diagnostic apparatus for testing for viruses and antibodies to viruses, namely, lateral flow readers; medical diagnostic apparatus for testing for viruses and antibodies to viruses, namely, lateral flow test readers; blood testing apparatus, namely, lateral flow readers; medical diagnostic apparatus for testing for viruses and antibodies to viruses, namely, lateral flow kits consisting primarily of lateral flow readers, lancets, dropping pipettes, bags for medical waste, and also containing medical diagnostic test strips and medical diagnostic reagents; all of the above for use in detecting viruses including coronaviruses and antibodies to viruses including coronavirusesACTIVE—
035Business management, namely, data management; data collection services, namely, analysing and compiling business data; database management; business data analysis; compiling, analysing and retrieving data and information, namely, analysing and compiling business data; compilation of information into computer databases; business information, business advice and business consultancy services relating to the aforementionedACTIVE—
042Scientific and technological services and research and design relating thereto, namely, pharmaceutical research and development; scientific research and development; compiling data for research purposes in the field of medical science and medical consultancy; maintaining on-line databases for others; electronic data storage; software as a service SaaS services featuring software for reading, analysing, sending, receiving, and displaying medical and veterinary diagnostic testing data; platform as a service PaaS featuring computer software platforms for reading, analysing, sending, receiving, and displaying medical and veterinary diagnostic testing data; computer software customisation services; computer software design and development services; computer software consultancy; medical, laboratory services; scientific laboratory services; scientific laboratory services related to biochemicals; toxicology services; product design and development of medical diagnostic testing apparatus and reagents; laboratory research services relating to pharmaceuticals; design and development of medical diagnostic testing software; product design and development in the field of medical and veterinary diagnostic equipment, apparatus, and instruments, including lateral flow readers and medical and veterinary diagnostic test kits; storing and retrieving data and information, namely, electronic data storage and public document retrieval; medical information retrieval, namely, searching and retrieving information available on computer networks for others; advice and consultancy services relating to the aforementioned; all of the above for use in relation to viruses including coronaviruses and antibodies to viruses including coronavirusesACTIVE—
044Medical diagnostic testing services; medical diagnostic testing relating to human or animal health; medical diagnostic testing services relating to immunodiagnostic testing, including testing for the presence of drugs or other analytes in biological fluids or other matrices; medical testing and analysis services for diagnostic and treatment purposes; medical testing services relating to the diagnosis and treatment of disease; providing medical information; medical diagnostic testing services, namely, conducting of quick tests, lateral flow assays, lateral flow immunoassays, symptom-based diagnostics; medical information, advice and consultancy services relating to the aforementioned; all of the above for use in relation to viruses including coronaviruses and antibodies to viruses including coronavirusesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (R.PR): Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.

DateCodeEventWhat it means
Feb 1, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 29, 2021DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Dec 29, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 22, 2021IUCNNOTICE OF ALLOWANCE CANCELLED—
Nov 22, 2021D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Sep 29, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 29, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Sep 29, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Sep 29, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 29, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 1, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 6, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 6, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 22, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 22, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 22, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 22, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 22, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 17, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 26, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 4, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 4, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 4, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 22, 2020GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 22, 2020GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 22, 2020CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 8, 2020DOCKASSIGNED TO EXAMINER—
May 5, 2020TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
May 5, 2020PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 27, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 20, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance